NCSK distributes Appreciation Certificates among Outstanding Safai Karamcharis (See 'Corp Brief') Stakeholders explore actionable measures to promote inclusivity across financial institutions (See 'Corp Brief') SEBI - Writ court's intervention not needed in respect of a preliminary SCN proposing to conduct an inquiry & giving opportunity to petitioner to present objections: HC (See 'Legal Desk') EPFO urges establishments to utilize Employees' Enrolment Campaign, 2026 (See 'Corp Brief') SEBI - Regulator cannot substitute its own commercial judgment for business decision of a company in relation to funding its wholly owned subsidiary: SAT (See 'Legal Desk') MoS delivers inaugural address at BRICS Science Ministerial Meet at Chennai (See 'Corp Brief') SEBI - Noticee cannot be held liable for carrying out unregistered investment advisory activities or for promising assured returns where evidence does not exist to show that Noticee conducted core advisory activities: SEBI (See 'Legal Desk') Procurement of tyres: CCI imposes penalty on Rekha Agencies and SS Marketing (See 'Corp Brief') Sonowal inaugurates Rs 428 Crore Projects at Paradip Port (See 'Corp Brief') Committee discusses Next Phase of UDAN & strengthening of Pilot Training Ecosystem (See 'Corp Brief') IPR - Trademark registration is liable for cancellation u/s 57(2) of Trade Marks Act if it is made without sufficient cause: HC (See 'Legal Desk') Office of Pr. CCA, Delhi, celebrates National Senior Citizens Day (See 'Corp Brief') 29 FDI Investments worth Rs.4,895 Crore reported under Revised Framework (See 'Corp Brief') Aadhaar App crosses 5 crore Downloads (See 'Corp Brief') SARFAESI - In respect of monies recoverable from a defaulting entity, the dues payable to a bank, being financial creditor, do not take precedence, over dues owed to the EPFO: HC (See 'Legal Desk') CSIR-CRRI and CSIR-AMPRI organise Workshop on Innovative Materials (See 'Corp Brief') DFS organises Workshop to Strengthen Implementation of Reservation Policy (See 'Corp Brief') IBC - Payment or transaction involving company's assets during insolvency moratorium without court approval is illegal: NCLT (See 'Legal Desk') Experts from DGFT, EXIM Bank and Digital Commerce share Practical Insights with MSMEs (See 'Corp Brief') Chhattisgarh emerges as First inland State to initiate Exports of Value-Added Tilapia products (See 'Corp Brief') IBC - Writ remedy cannot be invoked where petitioner does not challenge any order passed by either Tribunal but merely seeks directions relating to listing, constitution of special bench & restraint on pending proceedings - costs of Rs 25000 imposed on petitioner: HC (See 'Legal Desk') Digital Public Infrastructure is a Necessity, not a Luxury: MoS (See 'Corp Brief') IPR - Fundamental test in trade dress passing off action is one of overall impression and similarity, rather than side-by-side comparison of minor differences: HC (See 'Legal Desk') RDI Fund 'Conflict of Interest' policy protected by Stringent Safeguards: MoS (See 'Corp Brief') BRICS Youth Council Meeting and BRICS Youth Summit held successfully in Gandhinagar (See 'Corp Brief') PMLA - Accused has no vested or matter-of-right entitlement to conversion of non-bailable warrant into bailable warrant: HC (See 'Legal Desk') RM to hold bilateral talks with his Japanese counterpart in New Delhi (See 'Corp Brief') IBC - Only crystallised claims as on effective date are payable on pro-rata basis from designated Operational Creditors Settlement Amount: SC (See 'Legal Desk') 'Friends of MY Bharat': A New Global Youth Connect launched (See 'Corp Brief') RDDBFI - Borrowers cannot cherry-pick figures from bank certificates while ignoring standard accounting treatment of interest after NPA classification: SC (See 'Legal Desk') Tete-a-tete around AI in banking sector often begins with algorithms (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.